Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
The Wegovy pill is for adults with obesity or overweight and weight-related health conditions
Focus instead on lean proteins, fiber-rich carbs, and moderate healthy fats spread across smaller meals
It said the review would consider safety data, including adverse drug reactions reported by patients and clinicians to the MHRA
Reputable providers are transparent about total pricing
How much does tirzepatide cost without insurance